Sitewide Sale: Create a Free Seeking Alpha Account
Join the world's leading investor community and get 20% off your first year of any Seeking Alpha service.

or
By creating an account using any of the options above, you agree to the Terms of Use & Privacy Policy

NVO Novo Nordisk A/S
Stock Price & Overview

$69.020.51 (+0.74%)4:00 PM 06/30/25
NYSE | $USD | Post-Market: $69.50 +0.48 (+0.70%) 7:59 PM

NVO Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

Ratings Summary

People Also Follow

Similar to NVO

ETFs Holding NVO

NVO Company Profile

Novo Nordisk A/S logo
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Employees
77,406
Founded
1923
Address
  • Novo Alle 1
  • Bagsvaerd, 2880
  • Denmark
Phone Number
45 44 44 88 88

NVO Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

NVO Dividend Growth History

NVO Ownership

NVO Peers

Risk

Technicals

NVO Transcripts

Investor Presentations

NVO SEC Filings

NVO Income Statement

NVO Balance Sheet

NVO Cash Flow Statement

NVO Long Term Solvency

Novo Nordisk A/S (NVO) Frequently Asked Questions